BUZZELLI, GIAMPIERO
 Distribuzione geografica
Continente #
NA - Nord America 943
EU - Europa 525
AS - Asia 49
AF - Africa 1
Totale 1518
Nazione #
US - Stati Uniti d'America 938
IE - Irlanda 141
SE - Svezia 118
UA - Ucraina 81
IT - Italia 68
DE - Germania 49
FI - Finlandia 36
CN - Cina 22
TR - Turchia 16
GB - Regno Unito 15
JO - Giordania 9
CA - Canada 5
RU - Federazione Russa 5
FR - Francia 4
NL - Olanda 4
BE - Belgio 3
HK - Hong Kong 1
IR - Iran 1
RS - Serbia 1
SC - Seychelles 1
Totale 1518
Città #
Chandler 162
Dublin 141
Jacksonville 140
Fairfield 101
Cambridge 58
Wilmington 51
Woodbridge 44
Ashburn 39
Buffalo 36
Princeton 36
Houston 32
Seattle 30
Boardman 25
Medford 22
Ann Arbor 21
Boston 20
Lawrence 17
Altamura 16
Beijing 14
Izmir 11
Norwalk 8
Auburn Hills 5
Philadelphia 5
Dearborn 4
Falls Church 4
Florence 4
Frankfurt Am Main 4
Milan 4
Salerno 4
San Diego 4
Toronto 4
Andover 3
Bremen 3
Brussels 3
Verona 3
Guangzhou 2
Kunming 2
Los Angeles 2
Meppel 2
Redmond 2
Ardabil 1
Arezzo 1
Belgrade 1
Central 1
Civitanova Marche 1
Costabissara 1
Dallas 1
Hefei 1
Montréal 1
Nanjing 1
Ningbo 1
Old Bridge 1
Saint Petersburg 1
San Mateo 1
Taizhou 1
Totale 1103
Nome #
Effect of antiviral treatment in patients with chronic HCV infection and t(14;18) translocation 84
Albumin improves the response to diuretics in patients with cirrhosis and ascites: results of a randomized, controlled trial. 82
"Inapparent" hepatitis B virus infection and hepatitis C virus replication in alcoholic subjects with and without liver disease 80
Systemic hemodynamics and renal function in cirrhotic patients during plasma volume expansion. 79
Interferon and thymosin combination therapy in naive patients with chronic hepatitis C. Preliminary results 75
Impaired response to alpha interferon in patients with an inapparent hepatitis B and hepatitis C virus coinfection 74
Relevance of inapparent coinfection by hepatitis B virus in alpha interferon-treated patients with hepatitis C virus chronic hepatitis 63
Therapeutic and antilipoperoxidant effects of silybin-phosphatidylcholine complex in chronic liver disease: Preliminary results 61
Alterazioni del sistema pPAF-AH/PAF in pazienti con infezione cronica da HCV 57
Chemotherapy of primary and secondary liver cancer: is it useful? 54
Chronic viral hepatitis induced by hepatitis C but not hepatitis B virus infection correlates with increased liver angiogenesis 54
Alcoholic hepatopathy in Tuscany. Preliminary results of a multicenter study 46
Epidemiological aspects of chronic viral hepatitis 45
[Viral liver cirrhosis: natural course, pathogenesis and clinical implications of the complications] 40
Long course and prognostic factors of virus-induced cirrhosis of the liver. 40
Action of acute ethanol intake on rat biliary secretion: effect of epomediol. 40
Circulating growth hormone and insulin-like growth factor-I in nonalcoholic liver cirrhosis with or without superimposed hepatocarcinoma: evidence of an altered circadian rhythm. 39
Functional and ultrastructural changes in the liver during CDCA treatment. 38
EFFECTS OF RECOMBINANT HUMAN GAMMA-INTERFERON ON ADVANCED HEPATOCELLULAR CARCINOMA 34
The bromosulphthalein loading test in chronic alcoholic liver diseases. 32
Effects of recombinant human gamma-interferon on advanced hepatocellular carcinoma 31
Therapy of chronic active hepatitis C with alfa interferon: effectiveness and prognostic factors 31
Can serum bile acid determination substitute BSP loading test in detecting and monitoring chronic liver diseases? 31
Plasma PAF-AH biological activity decreases in patients with HCV chronic infection 31
Terapia interferonica dell'epatite cronica attiva HCV-correlata con e senza cirrosi 27
Epatite da virus C e terapia interferonica 27
L'Impiego dell'INterferone Alfa Ricombinante nel Trattamento della Cirrosi Attiva anti-HCV positiva. 27
La Cirrosi Epatica Virus-correlata: Storia Naturale, patogenesi e implicazioni cliniche dellew complicanze. 27
Interferon alfa + Ribavirin (RIBA) therapy for chronic hepatitis C (CHC) patients non responders to interferon alfa monotherapy 26
THERAPY OF CHRONIC ACTIVE HEPATITIS C WITH ALFA INTERFERON:EFFECTINEVESS AND PROGNOSTIC FACTORS 25
Epidemiological aspects of chronic viral hepatitis 24
Virological analysis of the healthy HCV carrier state: prognostic factors and HCV persistence in non viraemic subjects 23
Modifications of Plasma PAF-AH activity in Patients with Chronic HCV infection 22
Recenti dati sulle epatiti virali acute e croniche 19
Elementi epidemiologici e di importanza sociale delle epatiti virali. 19
Therapy Of Chronic Active Hepatitis-C With Alpha-Interferon - Effectiveness And Prognostic Factors 14
Totale 1521
Categoria #
all - tutte 2791
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2791


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/201850 0000 00 00 1613210
2018/2019136 5720 242 90 1154130
2019/2020280 1825432 2042 2641 1917333
2020/2021229 2752719 036 926 13311224
2021/2022199 22847 33 310 236767
2022/2023538 52603634 66118 8635 51000
Totale 1521